These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 28687273)

  • 1. Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges.
    Cerreia Vioglio P; Chierotti MR; Gobetto R
    Adv Drug Deliv Rev; 2017 Aug; 117():86-110. PubMed ID: 28687273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental cocrystal screening and solution based scale-up cocrystallization methods.
    Malamatari M; Ross SA; Douroumis D; Velaga SP
    Adv Drug Deliv Rev; 2017 Aug; 117():162-177. PubMed ID: 28811184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals.
    Healy AM; Worku ZA; Kumar D; Madi AM
    Adv Drug Deliv Rev; 2017 Aug; 117():25-46. PubMed ID: 28342786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical cocrystals, salts and polymorphs: Advanced characterization techniques.
    Pindelska E; Sokal A; Kolodziejski W
    Adv Drug Deliv Rev; 2017 Aug; 117():111-146. PubMed ID: 28931472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms by which moisture generates cocrystals.
    Jayasankar A; Good DJ; Rodríguez-Hornedo N
    Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocrystal and its Application in the Field of Active Pharmaceutical Ingredients and Food Ingredients.
    Wang N; Xie C; Lu H; Guo N; Lou Y; Su W; Hao H
    Curr Pharm Des; 2018; 24(21):2339-2348. PubMed ID: 29788878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocrystals, Salts, and Salt-Solvates of olanzapine; selection of coformers and improved solubility.
    Gong W; Mondal PK; Ahmadi S; Wu Y; Rohani S
    Int J Pharm; 2021 Oct; 608():121063. PubMed ID: 34481007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism and crystallization of active pharmaceutical ingredients (APIs).
    Lu J; Rohani S
    Curr Med Chem; 2009; 16(7):884-905. PubMed ID: 19275600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities.
    Cavanagh KL; Maheshwari C; Rodríguez-Hornedo N
    J Pharm Sci; 2018 Jan; 107(1):113-120. PubMed ID: 29097226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design.
    Berry DJ; Steed JW
    Adv Drug Deliv Rev; 2017 Aug; 117():3-24. PubMed ID: 28344021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Examination of Water Vapor Sorption by Multicomponent Crystalline and Amorphous Solids and Its Effects on Their Solid-State Properties.
    Newman A; Zografi G
    J Pharm Sci; 2019 Mar; 108(3):1061-1080. PubMed ID: 30391302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.
    Elder DP; Holm R; Diego HL
    Int J Pharm; 2013 Aug; 453(1):88-100. PubMed ID: 23182973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of Poor Solubility of a Salt-Cocrystal Hydrate: A Case Study of the Common-Ion Effect in Betrixaban, an Anticoagulant Drug.
    Devarapalli R; Indukuri A; Bollineni M; Mondal A; Reddy CM; Chennuru R
    Mol Pharm; 2021 Mar; 18(3):1138-1149. PubMed ID: 33528261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and Quality Control of Pharmaceutical Cocrystals.
    Izutsu KI; Koide T; Takata N; Ikeda Y; Ono M; Inoue M; Fukami T; Yonemochi E
    Chem Pharm Bull (Tokyo); 2016 Oct; 64(10):1421-1430. PubMed ID: 27319284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding.
    Karki S; Friscić T; Jones W; Motherwell WD
    Mol Pharm; 2007; 4(3):347-54. PubMed ID: 17497885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced methodologies for cocrystal synthesis.
    Douroumis D; Ross SA; Nokhodchi A
    Adv Drug Deliv Rev; 2017 Aug; 117():178-195. PubMed ID: 28712924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocrystal dissociation in the presence of water: a general approach for identifying stable cocrystal forms.
    Eddleston MD; Madusanka N; Jones W
    J Pharm Sci; 2014 Sep; 103(9):2865-2870. PubMed ID: 24824298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical salts and cocrystals involving amino acids: a brief structural overview of the state-of-art.
    Tilborg A; Norberg B; Wouters J
    Eur J Med Chem; 2014 Mar; 74():411-26. PubMed ID: 24487190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical Cocrystal: An Antique and Multifaceted Approach.
    Panzade PS; Shendarkar GR
    Curr Drug Deliv; 2017; 14(8):1097-1105. PubMed ID: 27758692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.